1.    Gopinathan P*, Liu CH*, Chiang NJ*, Huang CJ, Tu HC, Hung SC, Shan YS, Lee GB.  Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma. Sensors and Actuators B: Chemical. 346: 130526, 2021. (*Co-first author)

2.    Chang KY, Chiang NJ, Wu SY, Yen CJ, Chen SH, Yeh YM, Li CF, Feng X, Wu Katherine, Amanda Johnston, John S Bomalaski, Wu BW, Gao J, Sumit K Subudhi, Ahmed O Kaseb, Jorge M Blando, Shalini S Yadav, Peter W Szlosarek, Chen LT.  Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers. Oncoimmunology. 12;10(1):1943253, 2021.

3.    Chiang NJ, Chen LT, Shan YS, Yeh CN, Chen MH.  Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials. Biomolecules. 13;11(1):97, 2021.

4.    Shiah HS*, Chiang NJ*, Lin CC, Yen CJ, Tsai HJ, Wu SY, Su WC, Chang KY, Wang CC, Chang JY, Chen LT.  Phase I dose escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors. The Oncologist. doi:10.1002/onco.13612, 2020. Online ahead of print. (*Co-first author)

5.    Gopinathan P*, Chiang NJ*, Wang CH, Sinha A, Tsai YC, Tu HC, Hung SC; Hsu PH, Shan YS, Lee GB.  Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients. Sensors and Actuators B: Chemical. 322: 128569, 2020. (*Co-first author)

6.    Chiang NJ, Chen MH, Yang SH, Hsu C, Yen CJ, Tsou HH, Su YY, Chen JS, Shan YS, Chen LT.  Multicentre, Phase II Study of Gemcitabine and S-1 in Patients With Advanced Biliary Tract Cancer: TG1308 Study. Liver Int. 40(10):2535-2543, 2020.

7.    Chiang NJ, Tsai KK, Chen JS, Yang SH, Hsiao HH, Shan YS, Chen LT.  A Multicenter, Phase I/II Trial of Biweekly S-1, Leucovorin, Oxaliplatin and Gemcitabine in Metastatic Pancreatic Adenocarcinoma -TCOG T1211 Study. European Journal of Cancer. 124: 123-130, 2020.

8.    Gopinathan P*, Chiang NJ*, Bandaru A, Sinha A, Huang WY, Hung SC, Shan YS, Lee GB.  Exploring Circulating Tumor Cells in Cholangiocarcinoma Using a Novel Glycosaminoglycan Probe on a Microfluidic Platform. Adv Healthc Mater. 9(10):e1901875, doi: 10.1002/adhm.201901875, 2020. (*Co-first author)

9.    Su YY*, Chiang NJ*, Tsai HJ, Yen CJ, Shan YS, Chen LT.  The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort. Sci Rep 10(1):7420, 2020. (*Co-first author)